NCT03816163 2026-03-12A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerAstellas Pharma IncPhase 2 Active not recruiting393 enrolled
NCT03504397 2026-02-13SpotlightAstellas Pharma IncPhase 3 Active not recruiting565 enrolled 63 charts 1 FDA
NCT03653507 2026-02-06GLOWAstellas Pharma IncPhase 3 Active not recruiting507 enrolled 65 charts 1 FDA
NCT06396091 2025-11-13A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic CancerAstellas Pharma IncPhase 1 Active not recruiting12 enrolled